HSP90AA1 and chronic myelogenous leukemia, BCR-ABL1 positive: The compound, 4-(4-pyridinylmethylene) curcumin (C1206), suppresses the ATPase activity of Hsp90, leading to the inhibition of chronic myeloid leukemia (CML) cell proliferation [169].